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Veterinary drugs, such as coccidiostats and anthelmintics are routinely administered in extensive animal
husbandry, finding their way into the aquatic environment through urine and/or feces of treated animals
kept outdoors or by the application of contaminated liquid manure on agricultural fields and subsequent
mechanisms of surface run-off, leaching and drift. Several of these compounds are known to exert acute
and chronic toxicity effects on aquatic organisms, and can lead to changes in biodiversity and ecosystem
functioning. The overall objective of this research was to develop, validate and apply a highly sensitive,
multi-residue SPE-UHPLC-MS/MS method for the determination of 12 coccidiostats, registered as a feed
supplement or veterinary medicine in Europe and three regularly used anthelmintics, in pond water,
often functioning as amphibian habitat. Sample extraction was optimized using a fractional factorial
resolution design. Pond water filtration efficiency (i.e. 80–118%, #25% RSD) and matrix effects (i.e. 72–
119%, #39% RSD) were evaluated using water from respectively 3 and 20 different ponds in Flanders. By
incorporating internal standards, overall results improved and adequate precision values (i.e. #15%) were
obtained according to the EMA guidelines. Acceptable within-run and between-run apparent recoveries,
satisfactory precision as well as good linearity were demonstrated according to the CD 2002/657/EC,
SANTE/12682/2019 and VICH 49 guidelines, except for robenidine for which the between-day precision
was between 21.0 and 34.5%. Sample storage stability studies indicated that storage at 4 C and analysis
performed within 96 hours after sampling was sufficient to avoid loss by degradation for all compounds,
excluding robenidine. Values for the limit of detection (LOD) and quantification (LOQ) were in
nanograms per liter, which was essential for the environmental application of this novel method. The
method was successfully applied on grab water samples from the water surface of 18 different ponds
across Flanders, Belgium, detecting amprolium and levamisole at concentrations below the LOQ of
2.5 ng L1 and at 250.0 ng L1 or below the LOQ of 250.0 ng L1, respectively. In conclusion, our newly
developed method may provide insights about the contamination status of amphibian breeding ponds.Environmental signicance
This study provides the rst SPE-UHPLC-MS/MS method for the simultaneous quantication of 12 coccidiostats registered as feed additives or veterinary
medicine in Europe and three frequently used anthelmintics, in pond water. Our newly developed method provides information about pond water health, i.e.
contamination status and potential toxicity to aquatic organisms including aquatic microorganisms and amphibians. The method will be applied in the
establishment of a mechanistic model of food-web and infectious disease dynamics in natural ponds, in which the relationship between contaminants, aquatic
microorganisms and amphibians (i.e. food-web) and the relationship between all the latter and chytrid infections (i.e. infectious disease dynamics) will be
studied. As such, the method may contribute to highly demanded mitigating strategies, preventing further loss of biodiversity worldwide.cology, Toxicology and Biochemistry,
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Fig. 1 Chemical structures of lasalocid (1), maduramicin (2), monensin (3), narasin (4), salinomycin (5), semduramicin (6) (ionophoric cocci-
diostats) and amprolium (7), diclazuril (8), halofuginone (9), 4,40-dinitrocarbanilide (10), robenidine (11) and toltrazuril (12) (non-ionophoric
coccidiostats).
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View Article Online1. Introduction
Veterinary drugs and feed additives are widely used in animal
farming for the prevention and treatment of disease and the
overall protection of animal health. Many of these compounds,
such as coccidiostats and anthelmintics are routinely admin-
istered to avoid economic losses related to disease in extensive
animal husbandry.1 Coccidiostats are a group of compounds
that are regularly added in feed and used for the prevention and
treatment of coccidiosis, an infectious disease caused by
protozoa of the genus Eimeria and responsible for gastroenter-
itis in poultry and livestock.2 Currently, 12 coccidiostats are
registered in Europe, either as a feed supplement (n ¼ 11)3 or as
a veterinary medicine (i.e. toltrazuril).4 These compounds can
be categorized in non-ionophoric coccidiostats (amprolium,
diclazuril, halofuginone, nicarbazin, robendine and toltrazuril)
and ionophoric coccidiostats (lasalocid, maduramicin, mon-
ensin, narasin, salinomycin and semduramicin), the latter
naturally produced by certain strains of Streptomyces. Nicarba-
zin is the generic name for the complex of 4,40-dini-
trocarbanilide (4,40-DNC) and 2-hydroxy-4,6-
dimethylpyrimidine (HDP). However, 4,40-DNC is mostly
monitored for its persistence in the environment.2 The chem-
ical structure of coccidiostats consists of multiple cyclic ethers
and is shown in Fig. 1. Because ionophoric coccidiostats form
complexes with cations such as K+, Na+, Ca2+ and Mg2+ and are
lipid soluble, they are able to conduct cation transport across
the cell membrane which results in osmotic imbalance. In this
way these compounds induce parasitic cell death.5 Non-
ionophoric coccidiostats act by interfering with either theFig. 2 Chemical structures of flubendazole (1), levamisole (2) and iverm
This journal is © The Royal Society of Chemistry 2020mitochondrial metabolism, oxidative phosphorylation or cell
division.6
An important group of veterinary drugs are anthelmintics,
which are used for treating parasitic worm (helminths) infec-
tions, very oen as group medication in cattle, pig and poultry
industry.7,8 Levamisole belongs to the group of imidazothiazoles
which is characterized by a chemical structure containing an
imidazole and thiazole ring (Fig. 2). It works as a nicotine
receptor agonist that causes continued parasitic muscle
contractions, leading to paralysis.9 Flubendazole is a major
representative of the group of benzimidazoles which contain
a benzene and imidazole ring structure. These drugs exert their
function by inhibiting the synthesis of microtubules in the
cell.10 Ivermectin is an important macrocyclic lactone which
induces paralysis in nematodes by the overstimulation of
gamma-aminobutyric acid receptors.11 The chemical structures
of levamisole, ubendazole and ivermectin are presented in
Fig. 2.
Most of these compounds nd their way into the aquatic
environment by direct application in aquaculture, through
urine and/or feces of animals kept outdoors or by the applica-
tion of liquid manure on agricultural elds and subsequent
mechanisms of surface run-off, leaching to groundwater and
dri, the latter being displacement of aerosolized manure
droplets aer certain manure spraying techniques.12 Once in
the environment, these veterinary drugs can be subjected to
transport processes between different environmental compart-
ments (e.g. sorption–desorption) as well as removal processes
such as hydrolysis and photolysis, depending on the environ-
mental conditions and the specic physicochemical propertiesectin (3).
Environ. Sci.: Processes Impacts

































































































View Article Onlineof each compound (Table S1†).13 Even aer certain degrees of
metabolization in the animal body, degradation and different
sorption kinetics to sludge and soil, several coccidiostats and
anthelmintics have been found in river waters adjacent to
agricultural elds at concentrations of 15 ng L1 (monensin),
17 ng L1 (salinomycin) and 23 ng L1 (maduramicin).14 Several
of these compounds such as monensin, narasin, salinomycin,
lasalocid and ubendazole are known to exert acute (i.e. mostly
immobility) and/or chronic toxic effects (i.e. reproduction and
growth impairment) to aquatic organisms with reported half
maximal concentrations (EC50, 48h) for immobility ranging
between 0.045 and 403 mg L1 and lowest-observed-effect-
concentrations (LOEC21d) for reproduction or growth impair-
ment ranging between 0.005 and 0.09 mg L1 in daphnids and
rotifers. Furthermore, ivermectin has shown to be very toxic to
daphnids, with EC50, 48h for immobility ranging from 0.006 to
0.59 mg L1 and a reported LOEC21d of 0.001 ng L
1.15–20 As these
aquatic organisms are crucial elements in the aquatic foodweb,
their loss induces drastic changes in ecosystem functioning and
structure21 and even in aquatic vertebrate disease dynamics.22,23
Up to now, research has mainly focused on the detection of
coccidiostats and anthelmintics in rivers, large lakes, ground
and tap water.14,15,24,25 Only three papers have been published on
the determination of these veterinary products (n # 3) inTable 1 Mass spectrometric parameters for the 12 registered coccidio













4,40-Dinitrocarbanilide a C13H10N4O5 302.1 8.21 0.010
Amprolium c C14H19ClN4 278.1 0.90 0.012
Diclazuril b C17H9Cl3N4O2 406.0 8.63 0.010
Halofuginone c C16H17BrClN3O3 414.7 5.17 0.010
Lasalocid c C34H54O8 590.4 12.13 0.026
Maduramicin c C47H80O17 916.5 11.30 0.006
Monensin c C36H62O11 670.4 11.04 0.012
Narasin c C43H72O11 765.0 11.68 0.015
Robenidine c C15H13Cl2N5 333.1 7.04 0.012
Salinomycin c C42H70O11 750.5 11.43 0.015
Semduramicin c C45H76O16 872.5 10.76 0.006
Toltrazuril d C18H14F3N304S 425.4 8.93 0.017
Anthelmintics
Flubendazole c C16H12FN3O3 313.1 6.75 0.006
Ivermectin c C48H74O14 875.1 11.18 0.006




IS C13H2N4O5D8 310.3 8.21 0.023
diclazuril-methyl (b) IS C18H11Cl3N4O2 421.7 8.84 0.006
Nigericin (c) IS C40H68O11 725.5 11.71 0.010
Toltrazuril-d3 (d) IS C18H14F3N304SD3 428.4 8.94 0.010
a m/z ¼ mass-to-charge ratio; (A–B): collision energy for the quantier (A
retention time originating from 3 samples in three different analytical ba
Vanguard. Acquity HSS T3 UPLC pre-column (1.8 mm particle size).
Environ. Sci.: Processes Impactsnatural ponds.12,26,27 Comparing biodiversity of macrophytes
and macroinvertebrates, the European Pond Conservation
Network28 concluded that ponds at the regional level contribute
most to biodiversity by supporting more unique species as do
rivers, streams and ditches. Consequently, as research has
shown that several of the compounds mentioned above (e.g.
ivermectin, monensin, salinomycin) pose signicant treat to
aquatic organisms,16–20,29 it is highly recommended to deter-
mine the presence and concentration of these pharmaceuticals
in pond water as well.
A major challenge concerning environmental water (e.g. river
and ground water) analysis is the determination of low
concentrations (ng L1 range) which implies the need for
sensitive methods able to analyze a wide variety of environ-
mental pollutants. Analyzing pond water poses additional
challenges such as pH variability, the presence of organic
matter and the overall pond matrix complexity,30 which implies
the need for appropriate lters and internal standards.
Furthermore, a wide concentration range needs to be consid-
ered, ranging from low to high nanograms per liter, as detected
concentrations can depend on variable nearby agricultural
activities and livestock production,31 as well as pond size (i.e.
lower concentrations can be detected in larger ponds due to
















[M  H] 301.0 137.1 107.0 30 10–25
[M  Cl]+ 243.0 150.0 94.0 20 15–10
[M  H] 405.0 335.9 333.8 30 20–20
[M + H]+ 416.0 120.0 100.0 50 20–20
[M + Na]+ 613.2 595.2 377.2 30 20–30
[M + Na]+ 939.5 877.3 859.3 30 30–30
[M + Na]+ 693.39 675.3 461.3 40 40–40
[M + Na]+ 787.5 531.0 431.0 20 40–45
[M + H]+ 334.0 155.0 137.7 20 20–25
[M + Na]+ 773.1 431.3 531.4 30 50–50
[M + Na]+ 895.5 833.5 851.2 30 40–30
[M  H] 423.9 423.9 — 20 5
[M + H]+ 313.9 281.8 122.7 30 20–20
[M + Na]+ 897.3 752.9 609.0 30 40–40
[M + H]+ 204.8 177.9 122.9 30 10–20
[M  H] 309.1 141.0 111.0 30 10–20
[M  H] 420.9 348.0 321.0 40 30–30
[M + NH4]+ 742.3 729.6 657.2 30 30–30
[M  H] 426.9 426.9 — 20 5
) and qualier ion (B), respectively. b DtR ¼ standard deviation of the
tches using an Acquity HSS T3 UPLC column (1.8 mm particle size) and
This journal is © The Royal Society of Chemistry 2020

































































































View Article Onlinebetween ponds but also within ponds over time: ponds may be
smaller in size during prolonged warm periods for example in
spring and summer.32
This study provides the rst full-scale screening analysis of
toltrazuril and robenidine, and quantication of the other 10
coccidiostats registered as feed additive or veterinary medicine
in Europe3,4 and three regularly used anthelmintics33 in pond
water using solid phase extraction (SPE) combined with UHPLC-
MS/MS.
2. Material and methods
2.1 Chemicals and reagents
Concerning anthelmintics, one representative from three major
anthelmintic groups (i.e. macrocyclic lactones, benzimidazoles
and imidazothiazoles)33 was included in the method. Within each
group, compounds were selected based upon previous detection in
surface water in Belgium (i.e. ubendazole),34 sales data provided
by Elanco Animal Health (Antwerp, Belgium) showing high sales
percentages for ivermectin, and the fact that compounds are
registered as feed and/or drinking water medication (i.e. mass
medication) in Belgium.35 All analytical standards including the
selected internal standards (ISs) (i.e. DNC-d8, diclazuril-methyl,
nigericin and toltrazuril-d3) were purchased from Sigma-Aldrich
(Overijse, Belgium). A broad polarity range of compounds was
covered with log P values ranging from 1.04 to 7.51 (Table 1). Stock
solutions of amprolium, ubendazole, ivermectin, levamisole,
maduramicin, monensin, narasin, nigericin, salinomycin, sem-
duramicin, toltrazuril and toltrazuril-d3 were prepared in meth-
anol (MeOH) at a concentration of 1 mg mL1. Stock solutions of
lasalocid (0.1 mg mL1) and halofuginone (0.1 mg mL1) were
prepared in acetonitrile (ACN). Stock solutions of diclazuril and
diclazuril-methyl (0.1 mg mL1), 4,40-DNC and DNC-d8 (1 mg
mL1) and robenidine (1 mg mL1) were prepared in MeOH/n,n-
dimethylformamide (DMF) (90/10, v/v%), ACN/dimethylsulfoxide
(DMSO) (75/25, v/v%) and MeOH/DMSO (90/10, v/v%), respec-
tively. From the individual stock solutions, a mixed standard
working solution (WO1) of 0.5 mg mL
1 (i.e. amprolium, u-
bendazole and halofuginone), 4 mgmL1 (i.e. lasalocid), 5 mgmL1
(i.e. diclazuril, 4,40-DNC, maduramicin, monensin, narasin, robe-
nidine, salinomycin, semduramicin and toltrazuril) and 25 mg
mL1 (i.e. ivermectin and levamisole) was prepared in ACN. Serial
dilution resulted in mixed standard working solutions of 0.05, 0.4,
0.5 and 2.5 mg mL1 (WO2) and 0.005, 0.04, 0.05 and 0.25 mg mL
1
(WO3) in ACN, respectively. Additionally, a mixed standard
working solution (WOIS) (1 mg mL
1) containing the selected ISs
was prepared in ACN. Stock and working solutions were stored at
#15 C. A Milli-Q Advantage A10® System (Merck Millipore,
Darmstadt, Germany) was used to obtain ultrapure water. The
organic solvents were of UPLC grade, purchased from Biosolve BV
(Valkenswaard, The Netherlands). Formic acid (99.5%) and
ammonia solution (25.0%) was of UPLC grade, purchased from
Merck (Darmstadt). DMSO (99.5%, LC-MS grade) and DMF
(99.9%, HPLC grade) were provided by Sigma-Aldrich (Belgium).
Ammonium formate (UPLC grade) was procured fromBiosolve BV.
The Oasis® hydrophilic–lipophilic-balanced (HLB) cartridges
(500 mg, 6 mL) were purchased from Waters (Zellik, Belgium).This journal is © The Royal Society of Chemistry 20202.2 Instrumentation
Chromatographic separation was achieved using an Acquity H-
Class ultra-high performance liquid chromatograph (UHPLC)
system (Waters, Milford, USA) equipped with an Acquity HSS T3
100  2.1 mm UPLC column (1.8 mm particle size) and Acquity
Vanguard HSS T3 10  2.1 mm UPLC pre-column (1.8 mm
particle size), both from Waters. Column and autosampler
temperature were set at 45 C and 7 C, respectively. The
injection volume was 5 mL. Gradient elution was established
with a mobile phase consisting of 0.01% formic acid in Milli-Q
Ultrapure water (mobile phase A), MeOH/ACN (50/50, v/v%)
(mobile phase B) and MeOH containing 1 mM ammonium
formate (mobile phase C) at a ow rate of 0.3 mL min1. The
gradient program was as follows: 0.0–1.0 min, 85% A and 15%
B; 1.0–8.2 min: linear gradient to 5% A and 95% B; 8.2–9.0 min:
linear gradient to 100% C; 9.0–14.0 min: 100% C; 14.0–
14.2 min: linear gradient to 85% A and 15% B; 14.2–20.0 min:
85% A and 15% B. Analytes were detected using a Waters Xevo®
TQ-XS triple quadrupole mass spectrometer equipped with an
electrospray ionization (ESI) interface. The settings on the
Xevo® TQ-XS mass spectrometer were as follows: desolvation
gas ow rate: 800 L h1; desolvation temperature: 600 C; cone
gas ow rate: 150 L h1; source temperature: 150 C. The
capillary voltage was optimized at 3.0 kV and 2.5 kV for ESI
positive and ESI negative mode, respectively. Dwell times
between 10 and 110 ms per transition were selected for each
analyte separately. The Xevo® TQ-XS mass spectrometer was
operated in the selected reaction monitoring (SRM) mode. For
every compound, the most intense and second most intense
product ions were selected for quantication (i.e. quantier)
and qualication (i.e. qualier), respectively. The compound
specic MS/MS parameters at the selected ionization mode (ESI
negative or positive) are presented in Table 1.2.3 Sample preparation and solid-phase extraction
2.3.1 Extraction optimization. Five parameters that could
affect the extraction efficiency were selected based on literature,
i.e. the addition of ethylenediaminetetraacetic acid (EDTA) to
prevent complexation of ionophores with Ca2+, Mg2+ and
residual metal ions,12 the addition of sodium chloride (NaCl) to
facilitate conversion of ionophores into single sodium
adducts,36 acidication of the sample for a better interaction
between the SPE sorbent and the drug14 and different SPE
loading and elution volumes to improve sensitivity.15,37,38
Following a previously described approach,39 the soware
program JMP 12.0 (SAS Institute Inc, Cary, USA) was used to t
and model a statistical screening design (fractional factorial
resolution or FRR) consisting of 18 experiments taking into
account different options for the selected extraction parameters
(Table S2†). Experiments were conducted using tap water spiked
with each individual analyte to reach a concentration of
50 ng L1. To this extent, stock solutions were diluted with ACN
to establish individual working solutions with a concentration
of 0.5 mg mL1 and 500 mL water samples were spiked with 50
mL of the working solution. For each experiment, the normal-
ized peak areas of the analytes was summed (AUCSUM), takingEnviron. Sci.: Processes Impacts

































































































View Article Onlineinto account the number of analytes detected while ensuring
equal compound distribution. Using the statistical FFR design,
the optimized value for each of the selected extraction param-
eters was provided based on the highest AUCSUM. Obtained
results were evaluated to ensure a signal-to-noise ratio (S/N)$ 3,
adequate peak shape and baseline separation. One-way analysis
of variance (ANOVA) at a condence interval of 95% was used to
statistically evaluate responses and retain parameters with
a signicant effect (p-value < 0.05).
2.3.2 Sample preparation and extraction. Grab water
samples were collected with plastic buckets and sieved on spot
to eliminate large particles (Retsch® sieve, Novolab NV, Ger-
aardsbergen, Belgium, 250 mm, 50  200 mm). Samples were
transported in cooled glass amber bottles and stored for less
than 96 hours at 4 C. For each analyte, the appropriate volume
of mixed standard working solution was added to blank pond
water (500 mL) and carried throughout the extraction procedure
to establish a total of 10 calibration points. A detailed protocol
concerning the fortication of different calibrator samples was
added to the ESI (Table S3†). Furthermore, 25 mL of the IS
working solution (1 mg mL1) was added to 500 mL samples to
reach a concentration of 50 ng L1. All 500 mL samples were
ltered a second time through a 0.45 mm glass ber lter
(Whatman™, Buckinghamshire, UK) to remove solid particles.
Prior to extraction, the pH of each sample was measured and if
necessary, adjusted by acidication or alkalinization to achieve
a pH of 7 using formic acid or ammonia 25% solution,
respectively. An Oasis® hydrophilic–lipophilic balanced (HLB)
cartridge (6 mL, 500 mg, Waters) was used to extract analytes
from water and served as a cleanup and concentration step in
the sample preparation. The cartridge was pre-conditioned with
6 mL of methanol and 6 mL of ultrapure water to remove any
potential traces and liberate adsorption sites. Samples were
loaded under vacuum at 15 mmHg Next, the cartridge was
washed with 5 mL of ultrapure water and dried under vacuum
for 5 min. Analytes were eluted subsequently with 5 mL of
methanol and 5mL of methanol acidied with 0.1% formic acid
(i.e. concentration step). Finally, 200 mL of the combined eluate
was transferred to an UHPLC autosampler vial containing 50 mL
of ultrapure water followed by 10 seconds of vortex mixing. This
procedure resulted in an overall concentration factor of 40. All
vials were immediately subjected to UHPLC-MS/MS analysis.2.4 Method validation
Guidelines concerning validation for the analysis of micro-
pollutants in fresh water ecosystems are lacking. The only
European guideline that is available is CD 2009/90/EC in which
the water status is analytically evaluated by dening environ-
mental quality standards (EQS).40,41 It is stated in the guideline
that the measurement uncertainty must be below 50% and the
detection limit (LOD) has to be 30% below the EQS, the latter
dened as the concentration of a substance in water that should
not be exceeded in order to sustain the environmental quality
objective.41 In the directive, EQS are stated for several heavy
metals, pesticides and organic compounds based upon their
aquatic toxicity and bioaccumulating properties.42 However, noEnviron. Sci.: Processes ImpactsEQS are stated for any of the compounds included in the current
study and other validation guidelines, i.e. CD 2002/657 of the
European Commission,43 SANTE/12682/2019,44 EMA45 and
VICH 49 guidelines46 were consulted to ensure complete
analytical method validation. A set of parameters was used to
evaluate method performance: specicity, linearity, LOD and
limit of quantication (LOQ), pond water ltration efficiency,
matrix effects, within-day and between-day apparent recovery
(Rapp) (universally referred to as “trueness”), within-day and
between-day precision and carry-over. According to the Euro-
pean guideline CD 2002/657, laying down the performance
criteria of analytical methods, four identication criteria should
be fullled to ensure identity conrmation of the detected
analytes: one precursor and two product ions should be detec-
ted, the relative intensity of the detected product ions (i.e. ion
ratio) should correspond to the product ions of the calibration
curve (i.e. reference ion ratio) within accepted deviation
margins, the relative retention time of the analytes must range
within a margin of 2.5% and a signal-to-noise ratio (S/N) of at
least 3 is obtained for each compound. The ion ratio is calcu-
lated as the intensity (or peak area) ratio of the less intense
product ion (qualier) to that of the more intense product ion
(quantier). The reference ion ratio is calculated as an average
of ion ratios of calibration solutions. To assess compliance of
ion ratios in samples, the following equation was used:
Rel: diff : ¼ sample ion ratio reference ion ratio
reference ion ratio
 100% (1)
To ensure stringent method validation a maximum relative
difference of 30% was accepted according to the recent SANTE/
12682/2019 guideline, which is more strict than the European
guideline CD 2002/657.43,44
2.4.1 Specicity, linearity, LOD and LOQ. Specicity was
determined by investigating the absence of possible interfering
chromatographic peaks within the retention time margin of
2.5% for all analytes in three pond water samples, blank for the
compounds of interest. Different matrix-matched calibration
curves were obtained for different compounds with concentra-
tions ranging between 8 and 10 000 ng L1 (Table 2). The
coefficient of determination (R2) and goodness-of-t (g) (%)
were used to evaluate and conrm linearity, the latter being
a better criterion to evaluate the calibration curve, since it
considers the difference between the nominal values of the
calibration samples and the calculated concentration (eqn (2)).
According to the guidelines discussed above, acceptance criteria









% deviation ¼ calculated conc:  nominal value
nominal value
 100.
For the determination of the LOQ, blank samples were
spiked within the expected concentration range determined
during method optimization (8–10 000 ng L1). The LOD was
calculated as 3 times the standard deviation of the y interceptThis journal is © The Royal Society of Chemistry 2020
Table 2 Validation results for linearity (linear range, number of calibration points used to calculate linear range (n), coefficient of determination
(R2) and goodness-of-fit coefficient (g)), limit of quantification (LOQ) and limit of detection (LOD) for the coccidiostats and anthelmintics
included in the multi-residue UHPLC-MS/MS method
Linear range, ng L1 Calibration points, n R2 g, % LOD, ng L1 LOQ, ng L1
Coccidiostats
4,40-Dinitrocarbanilide 10–2000 9 0.9990 3.89 1.5 10
Amprolium 2.5–200 8 0.9943 8.91 1.3 2.5
Diclazuril 10–1000 8 0.9979 5.52 2.2 10
Halofuginone 2.5–200 8 0.9983 4.82 0.7 2.5
Lasalocid 8–1600 10 0.9990 3.95 1.5 8
Maduramicin 25–2000 7 0.9973 6.16 8.5 25
Monensin 10–2000 9 0.9983 5.19 4.0 10
Narasin 10–2000 8 0.9990 3.98 4.3 10
Robenidin 25–2000 7 0.9939 9.22 1.8 25
Salinomycin 10–2000 9 0.9988 4.39 2.7 10
Semduramicin 25–2000 7 0.9992 3.41 12.8 25
Toltrazuril 10–500 8 0.9977 5.63 4.3 10
Anthelmintics
Flubendazole 2.5–2000 10 0.9991 3.63 1.0 2.5
Ivermectin 125–10 000 7 0.9963 7.83 32.3 125
Levamisole 250–10 000 8 0.9980 5.08 40.0 250

































































































View Article Onlinedivided by the average slope of three independent calibration
curves. Furthermore, detected peaks and relative retention time
deviations (#2.5%) were evaluated and a S/N ratio $ 3 was
considered acceptable for the estimation of LOD. The LOQ was
determined using spiked samples as the lowest concentration
that could be analyzed within the limits of apparent recovery
and precision according to the guidelines described above.43
2.4.2 Filtration efficiency and matrix effects. Filtration
efficiency was determined by comparing peak areas of analytes
spiked before ltration (i.e. ltration step 1 and 2) to peak areas
of analytes spiked aer ltration at calibrator level no 8 (Table
S3†). To this extent, pond water samples were used, originating
from 3 different ponds in Flanders, situated in different
geological regions (Table S6†). The corresponding precision was
assessed by calculating the relative standard deviation (RSD, %)
of the obtained results per compound.
Matrix effects (ME) were assessed in pond water samples,
resulting from 20 different ponds in Flanders, Belgium (Table
S5†) and at two concentration levels, i.e. one low (calibrator no
5) and one high level (calibrator no 8) (Table S3†). Following the
approach described by Matuszweski et al. (2003),48 ME were
calculated as follows (eqn (3)):
ME ð%Þ ¼ B
A
 100 (3)
For which A denotes the peak area of the analyte in neat
solution and B the peak area of the analyte spiked aer extraction.
The corresponding precision was assessed by calculating the RSD
(%) of the obtained results per compound. Furthermore, ltration
efficiency, ME and corresponding precision were recalculated
using peak area ratios instead of absolute peak areas, to evaluate if
selected ISs could adequately compensate for loss of analyte due
to ltration and ME, and improve corresponding precision.This journal is © The Royal Society of Chemistry 20202.4.3 Apparent recovery, precision and carry-over. Within-
day and between-day apparent recovery (Rapp, %) is dened as
the ratio between the measured concentration and the theo-
retical (spiked) concentration and was determined by analyzing
respectively six and three blank samples spiked at three
different concentration levels (high, medium and low concen-
tration level) on three different days (Table S4†).46 The
measured concentration was calculated from a matrix-matched
calibration curve. According to the VICH 49 guideline, accep-
tance criteria for within-day and between-day Rapp are between
50 and 120%.46 However, to ensure rigorous validation, more
stringent acceptance criteria were applied, i.e. between 70 and
120%, as proposed by the SANTE/12682/2019 guideline.44
Within-day precision (repeatability) and between-day precision
(reproducibility) were determined by calculating the residual
standard deviation (RSD, %) of respectively 6 and 3 spiked
concentration levels during three subsequent days.46 According
to the VICH 49 guideline46 for the validation of analytical
methods, obtained RSD values must be #30% for the within-
day precision and #45% for the between-day precision when
dealing with analyte concentrations <1000 ng L1. However,
because the European guideline CD 2002/657 states that for
concentrations below 100 mg L1, values for precision should be
as low as possible, a maximum value of 25% was considered
acceptable for validation.43 Finally, carry-over was evaluated by
injecting three solvent samples containing ultrapure water and
MeOH (1/4, v/v%) directly aer the highest calibrator in each
curve. Ideally no peaks eluting at the same retention time as the
analyte should be detected. If however signal detection is
observed at equal retention time, the response of the peak
should not exceed 10% of the mean peak area of the analyte in
the LOQ samples.43,46
2.4.4 Sample storage stability study. To fulll the require-
ments of the EMA guidelines,45 stability was assessed for allEnviron. Sci.: Processes Impacts

































































































View Article Onlinecompounds at a high (cal. 8) and low (cal. 5) concentration level
in pond water samples originating from 3 different ponds. Grab
samples were collected in amber glass bottles and ltered
before dividing into 500 mL subsamples. Three subsamples per
pond were analyzed immediately to ensure the absence of
compounds and verify if the representative samples were truly
blank. Subsequently, three subsamples per pond were spiked
with a mixture of all 15 compounds to reach a high and low
concentration of 50, 400, 500 or 2500 ng L1, and 5, 40, 50 or
250 ng L1, respectively, according to the measured analyte
(Table S3†). Samples were stored at 4 C in the dark until
analysis 96 hours later. Prior to extraction, ISs were added and
each 500 mL sample was ltered, extracted and analyzed as
described before. Stability, expressed as recovery (RST), was
evaluated according to the method of Kruve et al. (2015)49 by
using the chromatographic peak areas, as follows (eqn (4)):
RST ð%Þ ¼ S96h
Sref
 100 (4)
where Sref represents the peak area of the compound analyzed
immediately aer spiking and S96h represents the peak area of
the compound analyzed aer 96 hours of storage in glass amber
bottles at 4 C. By using pond water from 3 different ponds,
situated in different geological regions, the applicability of the
stability test was assessed. Coordinates and corresponding soil
types of the 3 different ponds are presented in Table S6 of the
ESI† data.2.5 Application to environmental samples
The applicability of the method was evaluated using grab water
samples collected from 18 different ponds situated in agricul-
tural areas across Flanders, Belgium (Fig. 3). Samples were
taken between August and October 2018. Initial information onFig. 3 Site locations of the sampled fresh water ponds in Flanders, Belg
Environ. Sci.: Processes Impactspond localization in Belgium was provided by the database of
the Pondscape project,50 following a geographical selection to
those located in Flanders using QGIS 2.14 soware. Denitions
of the term ‘pond’may vary and there is no universal agreement
of what a pond is.28 However, in this study, we dened ponds
based on the study of Oertli et al. (2005)51 and Biggs et al.
(2005)52 as permanent or seasonal waterbodies between 1 m2
and 20 000 m2 in area, with a maximum depth of no more than
8 m. A eld study was performed to exclude permanent dried up
ponds or ponds with <1 m2 in area or >8 m in depth. Finally,
information on surrounding agricultural land use was gathered
through the Geopunt database (Land Cover Data 2018,
LANDBGBRP, shapele) and ponds without surrounding agri-
cultural activities within 200 m were withdrawn from the study.
Site locations, coordinates and surrounding agricultural land
use of the 18 selected ponds are presented in Fig. 3, Tables S7
and S8,† respectively. Three types of pond shape were distin-
guished, i.e. rectangular, elliptic and circular. Three locations
were identied along the shore of the ponds situated equidis-
tantly from each other. At two of these locations, surface water
was collected at <1 m from shore. At the third location surface
water was collected at >1 m from shore (Fig. S4†). Finally,
samples were sieved (Retch sieve®, 250 mm) and pooled per
pond. Following cooled transport, samples were stored at 4 C
until analysis within 96 hours.2.5 Data analysis
LC-MS/MS data acquisition and data processing were per-
formed with Masslynx soware version 4.2 (Waters).
Compound identication was realized by the relative intensity
of the detected ions corresponding to the ions of the calibra-
tion curve within accepted deviation margins, S/N ratio ($3)
and the retention time relative to that of the IS (deviation #ium.
This journal is © The Royal Society of Chemistry 2020
Fig. 4 SRM chromatograms of lasalocid (1), maduramicin (2), monensin (3), narasin (4), salinomycin (5), semduramicin (6) (ionophoric cocci-
diostats) and amprolium (7), diclazuril (8), halofuginone (9), 4,40-DNC ¼ 4,40-dinitrocarbanilide (10), robenidine (11), toltrazuril (12) (non-iono-
phoric coccidiostats), flubendazole (13), levamisole (14) and ivermectin (15) (anthelmintics) using the validated method on water samples spiked
at LOQ-concentration level. Quantification ions are shown.
This journal is © The Royal Society of Chemistry 2020 Environ. Sci.: Processes Impacts


































































































Table 3 Filtration efficiency (%) and corresponding precision (RSD, %)
of the 15 veterinary drugs included in themulti-residue UHPLC-MS/MS
method, using samples from 3 different ponds in Flanders, Belgium.
Samples were spiked at calibrator level no 8, i.e. 50, 400, 500 or
2500 ng L1, according to the measured analyte
Filtration
efficiency (%) RSD (%)
Mean (n ¼ 3) n ¼ 3
No IS With IS No IS With IS
Coccidiostats
4,40-Dinitrocarbanilide 89.6 112.9 12.4 6.7
Amprolium 102.7 104.3 2.7 8.6
Diclazuril 100.7 94.2 8.5 5.8
Halofuginone 107.8 112.0 5.1 0.1
Lasalocid 88.2 106.3 14.8 13.9
Maduramicin 80.8 96.1 12.7 12.8
Monensin 102.2 113.1 14.8 6.5
Narasin 90.4 109.1 14.2 15.1
Robenidine 79.5 95.0 25.0 9.1
Salinomycin 91.0 109.8 14.5 14.9
Semduramicin 91.7 93.6 0.1 4.5
Toltrazuril 101.8 101.5 1.4 11.6
Anthelmintics
Flubendazole 117.8 117.7 8.5 5.7
Ivermectin 105.7 94.0 24.5 10.1
Levamisole 80.2 106.9 5.9 3.2

































































































View Article Online2.5%), all being investigated from the corresponding reference
standard.
3. Results and discussion
3.1 Method development
3.1.1 UHPLC-MS/MS conditions. Tuning was performed by
direct infusion of a 10, 100 and 1000 ng L1 standard mix
working solution (ow: 10 mL min1) in combination with the
mobile phase (200 mL min1, A/B: 50/50, v/v) in positive (ESI+)
and negative ion (ESI) mode. According to the optimal signal
intensity for each analyte, adducts were selected as precursor
ion (i.e. [M + NH4]
+, [M + Na]+, [M + H]+ and [M  H]) and cone
voltages were optimized (Table 1). The ability of ionophoric
coccidiostats to bind sodium frequently results in the formation
of sodium adducts even with the use of UHPLC-MS/MS graded
solvents.53 However, amprolium lacks such ability and exists as
positively charged precursor ion in aqueous solution. For this
reason the cationic fraction of the molecule (without chloride)
was selected as precursor ion.54 Next, to determine the two most
optimal product ions for the SRM transitions, different collision
energies were applied. The most intense product ion was used
for quantication while other product ions were used for
identication (Table 1). In the case of toltrazuril, only the
precursor ion was selected for further optimization since
application of the collision energy yielded insufficient frag-
mentation patterns consisting of small fragments (<100 m/z)
with low signal intensity (<35%). For this reason, the detection
of this analyte is rather suitable for screening purposes, as it did
not yield a sufficient fragmentation pattern to meet the CD
2002/657 identication criteria.
An Acquity HSS T3 UPLC column (1.8 mm particle size) and
Vanguard Acquity HSS T3 UPLC pre-column (1.8 mm particle
size) was tested, based upon literature,55 resulting in narrow
and symmetric peaks. A selection of mobile phase compositions
was based upon literature.12,56 Two different buffer additives (i.e.
0.1% formic acid and 0.1% ammonium formate) were evaluated
for the aqueous (i.e. Milli-Q Ultrapure water) and organic
solvents (i.e. MeOH and ACN). Optimization of the organic
mobile phase demonstrated higher peak intensities for 7
compounds (i.e. ivermectin, lasalocid, maduramicin, mon-
ensin, narasin, salinomycin and toltrazuril) in the presence of
MeOH containing 0.1% ammonium formate, whereas higher
peak intensities were obtained in the presence of ACN/MeOH
(50/50, v/v%) for amprolium, diclazuril, 4,40-DNC, ubenda-
zole, halofuginone, levamisole and robenidine. Subsequently, it
was found that the combination of the Acquity HSS T3 column
with one aqueous (mobile phase A) and two organic (mobile
phase B and C) solvents gave the best retention, peak shape and
separation for all compounds within an acceptable run time of
20 minutes. These ndings are in line with literature using
three mobile phases and an ammonium formate additive for
the detection of various coccidiostats.57,58
By further studying the symmetry of the peak shape
(Asminimal ¼ 1.50 and Asoptimal ¼ 1.00) and resolution, the
optimal conditions of the stationary phase, ow rate, solvent
gradient, column temperature and injection volume wereEnviron. Sci.: Processes Impactsdetermined. Separation of the 15 compounds was achieved
covering a broad polarity range (log P ranging from 1.04 to 7.51)
with retention times ranging from 0.90 to 12.13 min (Table 1).
Chromatograms of each compound are presented in Fig. 4.
3.1.2 Sample extraction. Although solid-phase extraction is
the most commonly used technique for extracting veterinary
drugs from aquatic matrices, a direct and simple SPE-method
for the determination of coccidiostats and anthelmintics
remains challenging due to their diverse chemical structures
and properties2,14 (Table 1 and Fig. 1 and 2). For this reason, an
Oasis® HLB cartridge was selected to cover a broad polarity
range of compounds. The lipophilic divinylbenzene and
hydrophilic N-vinylpyrrolidone co-polymer in this cartridge
provided good results for all polar and apolar analytes included
in this study (log P ¼ 1.04–7.51) and no other purication
techniques were tested. Conditioning (i.e. MeOH and ultrapure
water) and elution solvents (i.e. MeOH) were selected based
upon previous literature,2,14,54,59 resulting in acceptable recov-
eries and sensitivity for all compounds, except for robenidine.
However, by subsequently eluting cartridges with methanol
acidied with formic acid, recoveries for robenidine (log P ¼
3.17) ameliorated. To avoid degradation of the acid labile
ionophores,60 samples were subjected immediately to UHPLC-
MS/MS analysis. Further optimization was performed using
a fractional factorial resolution experimental design in which
the effect of the selected parameters on the extraction efficiency
of the 15 compounds was assessed (Fig. S1†). The addition of
NaCl was not signicant (p-value > 0.05; F1,1 ¼ 4.7), whereas
addition of EDTA, pH adjustment of the sample, loading andThis journal is © The Royal Society of Chemistry 2020

































































































View Article Onlineelution volume exerted a signicant effect (p-value < 0.05 and
F1,1 ¼ 15.5, 5.5, 45.6 and 26.8, respectively) on AUCSUM of the
compounds (Fig. S2†). More specic, a higher AUCSUM was
observed in the absence of EDTA, higher elution volumes (>4
mL) and higher loading volumes (>300 mL) (Fig. S3†). For
practical reasons, an optimal loading volume of 500 mL was
selected since higher volumes tended to clog the sorbent phase,
resulting in long loading times. Additionally, best results were
obtained for samples at pH 7. In this respect, analyzing samples
with a pH value that differs greatly from 7 is considered less
optimal and sample pH should be adjusted accordingly
(Fig. S3†). These ndings are in line with previous research
regarding feed additives in the aquatic environment and are
related to the hemiacetal or ketal structures of the ionophores
that tend to be acid labile.603.2 Method validation
3.2.1 Specicity, linearity, LOD and LOQ. Good specicity
implicates the ability of the method to distinguish between the
target analyte and other substances present in the sample.43 No
interfering peaks (S/N ratio > 3) were detected within the
retention time margin of 2.5% for all analytes in any of the
blank samples analyzed, conrming the specicity of the
method. Linear calibration curves were constructed for each
compound and good linearity was obtained for all target
compounds with R2 $ 0.994 and g # 9.22% (Table 2). A
weighted least-squares regression (WLSLR) applying an optimal
weighing factor of 1/x2 was used to compensate the observed
heteroscedasticity. LOD values ranged from 0.7 to 12.8 ng L1Table 4 Results of the matrix effects (ME) and relative standard deviat
different ponds in Flanders, Belgium. Samples were spiked at calibrator le
high ¼ 50, 400, 500 or 2500 ng L1)
Mean ME (%), (n ¼ 20)
Low High
No IS With IS No IS
Coccidiostats
4,40-Dinitrocarbanilide 81.7 98.4 84.9
Amprolium 106.7 104.1 81.2
Diclazuril 94.2 99.3 101.0
Halofuginone 88.5 85.4 100.9
Lasalocid 84.9 84.2 93.1
Maduramicin 107.9 103.3 102.7
Monensin 108.9 103.2 102.7
Narasin 84.8 82.6 96.2
Robenidine 71.5 72.1 76.5
Salinomycin 88.3 85.3 89.3
Semduramicin 104.4 100.1 98.2
Toltrazuril 86.2 99.3 88.7
Anthelmintics
Flubendazole 99.6a 88.9a 119.1
Ivermectin 96.9 96.0 93.9
Levamisole 83.9 83.0 80.4
a Calculated on 7 pond water samples as other samples contained traces
This journal is © The Royal Society of Chemistry 2020for coccidiostats and from 1.0 to 40.0 ng L1 for anthelmintics.
LOQ values were between 2.5 and 25.0 ng L1 (coccidiostats)
and between 2.5 and 250.0 ng L1 (anthelmintics). Regarding
coccidiostats, obtained results are better than those reported in
previous literature using HPLC-MS/MS for the detection of
maximum 9 compounds in surface water.14,59,61 However,
a recent study, comprising a total of 26 coccidiostats in surface
and ground water showed lower values for LOD and LOQ for all
compounds, except for toltrazuril for which obtained values
were two times higher than those obtained in the current
study.25 To the authors' knowledge, no studies have been pub-
lished applying an UHPLC-MS/MS method for the detection of
coccidiostats in pond water. In comparison to a recent study
detecting multiple anthelmintics in surface water using
UHPLC-MS/MS,62 values for LOD and LOQ are slightly lower
than those obtained in the current study i.e. 0.1 and 1.0 ng L1
versus 1.0 and 2.5 ng L1 for ubendazole, respectively. These
ndings illustrate the well-known limitation of multi-residue
methodologies, where not the best conditions for all indi-
vidual target analytes can be achieved but a compromise on
nal analytical conditions has to be made, compromising on
method sensitivity. However, taking reported EC50, 48h and
LOEC21d values for various aquatic organisms into account, the
authors can state that the obtained LODs are sufficient to
evaluate potential ecotoxicity for the majority of the
organisms.16–20,29
3.2.2 Filtration efficiency and matrix effects. Experiments
showed good results for the ltration efficiency, with values
ranging between 80 and 118% for all compounds. Furthermore
adequate precision was demonstrated, with RSD values <20%ion (RSD) for each of the 15 veterinary drugs, using samples from 20
vel no 5 (i.e. low ¼ 5, 40, 50 or 250 ng L1) and calibrator level no 8 (i.e.
RSD (%), (n ¼ 20)
Low High
With IS No IS With IS No IS With IS
101.2 12.0 2.4 8.2 2.2
86.2 38.6 15.2 12.6 13.8
103.5 13.6 2.9 8.3 3.4
95.7 7.0 8.2 7.4 9.7
93.7 12.1 3.7 8.9 8.5
103.7 14.2 9.7 18.2 4.8
104.2 20.1 6.7 14.8 8.6
98.1 10.7 5.3 10.5 8.4
78.6 14.6 9.1 11.2 9.5
90.5 12.9 3.6 15.7 2.7
100.0 11.4 6.6 10.7 9.9
101.0 11.9 2.5 10.8 2.9
115.0 11.8a 5.1a 22.6 15.3
95.8 13.8 10.3 19.4 12.0
81.0 19.5 15.4 16.4 10.2
of ubendazole (i.e. 9–16 ng L1).
Environ. Sci.: Processes Impacts

































































































View Article Onlinefor all compounds, except for robenidine and ivermectin, for
which precision was 25%. However, by incorporating ISs,
precision values for robenidine and ivermectin improved,
resulting in RSD values of 9% and 3%, respectively. Results of
ltration efficiency and corresponding precision with and
without taking the ISs into account, are presented in Table 3.
Matrix effects are caused by competition between analyte
and co-eluting matrix compounds with primary ions formed in
the LC-MS/MS interface, resulting in an enhanced or sup-
pressed ionization of the analyte.48 Analyte quantication can
be strongly affected by matrix effects, which can be expected in
a complex matrix such as pond water, implying the need to
examine this further. According to the SANTE/12682/2019
criteria,44 obtained results for ME (n ¼ 20) were acceptable for
14 out of 15 compounds with values ranging between 81.7 and
108.9% for analytes spiked at low concentration, and between
80.4 and 119.1% for analytes spiked at high concentration.
Slightly lower values (i.e. 71.5 and 76.5%) were obtained for
robenidine. Furthermore, precision was evaluated between the
20 different samples, with RSD values ranging between 7.0 and
38.6% for analytes spiked at low concentration and 7.4 and
22.6% for analytes spiked at high concentration. By incorpo-
rating ISs, overall results for ME improved and adequate
precision values (i.e. #15%) were obtained according to the
EMA guidelines.45 Results conrm the suitability of the selected
ISs in our newly developed method. Details of ME are summa-
rized in Table 4. The use of ISs and a matrix-matched calibra-
tion curve was employed to address any potential ME, further
satisfying validation criteria.
3.2.3 Apparent recovery, precision and carry-over. The
validation parameters with respect to apparent recovery and
precision are presented in Table S4.† According to theTable 5 Mean recovery (RST) (n ¼ 3), standard deviation (SD) and stabl
storage for 96 hours at 4 C in amber glass bottles
Recovery (RST)
Mean  SD (%)
Low concentration
Coccidiostats
4,40-Dinitrocarbanilide 97.6  3.6
Amprolium 86.6  4.3
Diclazuril 98.6  3.9
Halofuginone 99.5  2.2
Lasalocid 115.6  8.8
Maduramicin 113.2  7.4
Monensin 102.1  11.9
Narasin 109.3  10.8
Robenidin 29.0  0.6
Salinomycin 100.8  5.0
Semduramicin 115.5  8.7
Toltrazuril 102.5  2.6
Anthelmintics
Flubendazole 103.1  4.4
Ivermectin 95.0  5.4
Levamisole 90.3  1.5
Environ. Sci.: Processes Impactspreviously described guidelines, Rapp results were within
acceptable limits for both group of compounds. Values for
within-day Rapp ranged between 73.4 and 112.8% and between
80.0 and 107.3% for all but one of the coccidiostats and
anthelmintics, respectively, spiked at high, medium and low
concentration level (Table S4†). Between-day Rapp ranged
between 73.5 and 112.6% for the coccidiostats and between 81.5
and 115.8% for anthelmintics, implying good accuracy of the
validated method. These results are comparable,2,14,15 more
variable25 or better62 (i.e. levamisole) than those reported in
previous studies detecting coccidiostats or anthelmintics in
freshwater. Overall, the within-day and between-day precision
RSDs were within acceptable limits, i.e. #25%, for all
compounds except for robenidine, for which the between-day
precision was between 21.0 and 34.5%. This nding could be
attributed to the well-known limitation of multi-residue meth-
odologies, where conditions are optimized for the group of
compounds rather than the individual analyte, resulting in
a compromise on nal analytical performance. For this reason,
the method may be less t for quantication of robenidine.
Finally, no carry-over was detected in any of the solvent samples
containing ultrapure water and methanol (1/4, v/v%) injected
directly aer the highest calibrator of every compound.
3.2.4 Stability of coccidiostats and anthelmintics in spiked
pond water samples. The stability of the investigated
compounds in a biologically active matrix such as pond water,
oen affected by anthropogenic and agricultural pollution, is
a crucial factor affecting the reliability of published data.
However, very little research has been performed on the
stability of coccidiostats and anthelmintics in pond water27
and half-lives in other aquatic matrices vary between and 7
and >34 days (Table S1†).62 In this study, the stability ofe storage time of coccidiostats and anthelmintics in pond water after
Stable storage
time (hours)High concentration
92.7  1.0 96
96.3  10.2 96
104.6  9.7 96
100.4  6.4 96
116.7  3.8 96
115.5  15.5 96
111.8  13.6 96
115.3  10.8 96
18.2  5.8 <96
108.8  17.2 96
112.8  13.9 96
111.7  12.1 96
112.7  11.5 96
108.3  2.6 96
97.4  18.7 96
This journal is © The Royal Society of Chemistry 2020

































































































View Article Onlinecoccidiostats and anthelmintics in pond water was evaluated
for all compounds aer 96 hours of storage at 4 C in amber
glass bottles. By using pond water from 3 different ponds,
situated in different geological regions, the applicability of the
stability test was assessed, as well. Results indicated that 14
out of 15 compounds were stable under storage conditions for
96 hours, reaching recoveries between 86.6 and 115.6% for
analytes spiked at high concentrations, and between 92.7 and
116.7% for analytes spiked at low concentrations (Table 5).
Robenidine was not stable under storage conditions for 96
hours, showing a recovery of 18.2 and 29.0% respectively, at
high and low spiking level. These ndings are in line with
previous research16,27,63 and indicate that analysis performed
within 96 hours was sufficient to avoid loss by degradation for
14 out of 15 compounds included in this method. In the case
of robenidine, no studies have been reported regarding the
stability in environmental waters to compare or support these
ndings.3.3 Environmental sample analysis
To demonstrate the applicability of the newly developed
UHPLC-MS/MS method, analysis of freshwater samples was
performed, originating from 18 different ponds in agricultural
areas in Flanders, Belgium. As the pH of each of the pond
samples did not differ greatly from 7 (Table S7†), no further pH
adjustment was necessary during sample preparation. Except
for amprolium, no coccidiostats were detected in any of the
ponds. Amprolium was present in one pond (i.e. LIE) at
concentrations below the LOQ (<2.5 ng L1), comparable to the
study of Song et al. (2007) in which the compound was detected
in surface run-off water from a livestock farm.38 Although recent
use as animal feed supplement and subsequent run-off, leach-
ing or dri from fertilized elds could account for the presence
in ponds situated in an agricultural landscape, the presence of
residues must be related to the physicochemical properties as
well. As an example, amprolium has a higher aqueous solubility
(i.e. 540 mg L1) and a lower log P (i.e. 1.04) than the other
coccidiostats, which could be an additional explanation for its
presence in the aquatic compartment.64 Furthermore, as robe-
nidine turned out to be unstable in pond water under the used
storage conditions, it is unlikely that it will be detected in pond
waters which are subject to varying temperature and sunlight,
unless it is recently used. Levamisole was present in one pond at
a concentration of 250.0 ng L1 (i.e. ZOT 8) and in all other
ponds at concentrations below the LOQ (<250.0 ng L1).
Although levamisole is extensively metabolized in most
species,65 it is not surprising that it has been detected in ponds
that are receiving run-off water (or contaminated groundwater)
from agricultural areas considering that levamisole is
a frequently oral and intramuscular administered anthelmintic
for pigs and cattle.33 Furthermore, levamisole exerts a high
aqueous solubility (i.e. 1440 mg L1) and has a lower log P value
than ubendazole and ivermectin, i.e. 2.36 versus 3.40 and 5.83,
respectively.66,67 Alternate use, low aqueous solubility (i.e.
4 mg L1 for ivermectin), higher log P values and a high ability
to bind to soil (Koc ivermectin ¼ 3981 L kg1) could account forThis journal is © The Royal Society of Chemistry 2020the fact that ivermectin and ubendazole were not detected in
any of the ponds, the latter drug being extensively metabolized
in mammals as well.68 For this reason, future studies, deter-
mining anthelmintic transformation products such as amino-
ubendazole and hydroxy-ubendazole metabolites are war-
ranted. Obtained results are in line with previous research
describing levamisole as most frequent and abundant detection
among different classes of anthelmintics including macrocyclic
lactones and benzimidazoles in river water originating from
agricultural areas.62 Due to the hydrophobic character of many
of the target compounds (log P $ 3), it is possible to have
accumulation in other compartments of the aquatic environ-
ment, such as sediment or biota, potentially posing an envi-
ronmental risk there, as well. This was, however, outside the
scope of this study.4. Conclusions
A novel, highly sensitive, multi-residue SPE-UHPLC-MS/MS
method was successfully developed and validated for the
simultaneous screening of toltrazuril and robenidine, and
quantication of the other 10 coccidiostats registered as feed
additives or veterinary medicine in Europe and three frequently
used anthelmintics, in pond water, covering a broad polarity
range of compounds (log P ¼ 1.04–7.51). Filtration efficiency,
matrix effects and corresponding precision were evaluated and
obtained results overall improved by incorporating internal
standards resulting in adequate values according to the EMA
guideline. Acceptable within-run and between-run apparent
recoveries, satisfactory precision as well as good linearity were
demonstrated according to the guidelines discussed above,
except for robenidine, for which the between-day precision was
between 21.0 and 34.5%. Storage stability studies indicated that
sample storage at 4 C and analysis performed within 96 hours
was sufficient to avoid loss by degradation for all compounds,
except for robenidine which implied its improbability of
detection in pond waters subject to varying temperature and
sunlight, unless recently used. Values for LOD and LOQ were in
nanograms per liter which was essential for the environmental
application of this novel method. The method was successfully
applied on water samples from 18 different ponds situated in
agricultural areas across Flanders, Belgium. Amprolium was
found in one pond at a concentration level below the LOQ of
2.5 ng L1 and levamisole was found in every pond at concen-
trations ranging between 250.0 ng L1 and below the LOQ of
250.0 ng L1. The former probably resulting from surface run-
off, leaching or dri aer applying liquid manure from recent
treated animals on elds in an agricultural landscape. In
conclusion, our newly developed method may provide insights
about the contamination status of freshwater ponds and the
potential toxicity to aquatic organisms.Conflicts of interest
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